What is the CureMILS Project?
The project - full name 'CureMILS - A reprogramming-based strategy for drug repositioning in patients with mitochondrial DNA-associated Leigh syndrome' - is an exciting research project which aims to develop therapies for mitochondrial DNA-associated Leigh syndrome (MILS).
Professor Prigione explains what the project involves in this 3 minute video.
IMP is a partner in the project, which is part of the European Joint Programme on Rare Diseases.
Click to watch.
Read more about the project.
